- Home
- ARIS vs CVAC Comparison
ARIS vs CVAC Comparison
Compare ARIS & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARIS
- CVAC
- Stock Information
- Founded
- ARIS 2015
- CVAC 2000
- Country
- ARIS United States
- CVAC Germany
- Employees
- ARIS N/A
- CVAC N/A
- Industry
- ARIS Water Supply
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- ARIS Utilities
- CVAC Health Care
- Exchange
- ARIS Nasdaq
- CVAC Nasdaq
- Market Cap
- ARIS 828.4M
- CVAC 818.8M
- IPO Year
- ARIS 2021
- CVAC 2020
- Fundamental
- Price
- ARIS $20.81
- CVAC $3.59
- Analyst Decision
- ARIS Buy
- CVAC Strong Buy
- Analyst Count
- ARIS 6
- CVAC 2
- Target Price
- ARIS $26.00
- CVAC $14.00
- AVG Volume (30 Days)
- ARIS 697.9K
- CVAC 527.9K
- Earning Date
- ARIS 05-06-2025
- CVAC 05-22-2025
- Dividend Yield
- ARIS 2.69%
- CVAC N/A
- EPS Growth
- ARIS 16.60
- CVAC N/A
- EPS
- ARIS 0.83
- CVAC 0.75
- Revenue
- ARIS $452,529,000.00
- CVAC $554,073,921.00
- Revenue This Year
- ARIS $12.52
- CVAC N/A
- Revenue Next Year
- ARIS $7.90
- CVAC $38.07
- P/E Ratio
- ARIS $25.13
- CVAC $4.66
- Revenue Growth
- ARIS 12.03
- CVAC 895.54
- 52 Week Low
- ARIS $13.34
- CVAC $2.22
- 52 Week High
- ARIS $33.95
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- ARIS 34.03
- CVAC 61.59
- Support Level
- ARIS $19.70
- CVAC $3.26
- Resistance Level
- ARIS $26.75
- CVAC $3.79
- Average True Range (ATR)
- ARIS 1.29
- CVAC 0.21
- MACD
- ARIS -0.31
- CVAC 0.02
- Stochastic Oscillator
- ARIS 15.74
- CVAC 73.00
About ARIS Aris Water Solutions Inc.
Aris Water Solutions Inc is an environmental infrastructure and solutions company delivering full-cycle water handling and recycling solutions. Its integrated pipelines and related infrastructure create long-term value by delivering high-capacity, comprehensive produced water management, recycling, and supply solutions to operators in the core areas of the Permian Basin. The company manages its business through a single operating segment comprising two primary revenue streams, Produced Water Handling and Water Solutions. The Produced Water Handling business gathers, transports, and unless recycled, handles produced water generated from oil and natural gas production, and the Water Solutions business develops and operates recycling facilities to treat, store, and recycle produced water.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.